MetaADEDB 2.0 @ LMMD
Desvenlafaxine Succinate
(PWPDEXVGKDEKTE-UHFFFAOYSA-N)
Structure
SMILES
CN(CC(C1(O)CCCCC1)c1ccc(cc1)O)C.OC(=O)CCC(=O)O.O
Molecular Formula:
C20H33NO7
Molecular Weight:
399.479
Log P:
2.6041
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
5
TPSA:
127.53
CAS Number(s):
386750-22-7
Synonym(s)
1.
Desvenlafaxine Succinate
2.
2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate
3.
4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
4.
Desvenlafaxine
5.
O-desmethylvenlafaxine
6.
O-desmethylvenlafaxine Succinate
7.
O-desmethylvenlafaxine Succinate Monohydrate
8.
Pristiq
9.
WY 45,233
10.
WY 45233
11.
WY-45,233
12.
WY-45233
13.
45,233, WY
14.
45233, WY
15.
Monohydrate, O-desmethylvenlafaxine Succinate
16.
O desmethylvenlafaxine
17.
O desmethylvenlafaxine Succinate
18.
O desmethylvenlafaxine Succinate Monohydrate
19.
Succinate Monohydrate, O-desmethylvenlafaxine
20.
Succinate, Desvenlafaxine
21.
Succinate, O-desmethylvenlafaxine
22.
WY45,233
23.
WY45233
External Link(s)
MeSHD000069468
PubChem Compound134715671
6918664
KEGGdr:D02570
Therapeutic Target DatabaseD03CEF
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 677
Canada Vigilance: 42
Canada Vigilance
US FAERS
2NauseaFAERS: 639
Canada Vigilance: 26
Canada Vigilance
US FAERS
3DizzinessFAERS: 558
Canada Vigilance: 19
Canada Vigilance
US FAERS
4HeadacheFAERS: 505
Canada Vigilance: 17
Canada Vigilance
US FAERS
5Drug withdrawal syndromeFAERS: 501
Canada Vigilance: 2
Canada Vigilance
US FAERS
6AnxietyFAERS: 417
Canada Vigilance: 20
Canada Vigilance
US FAERS
7Feeling abnormalFAERS: 396
Canada Vigilance: 12
Canada Vigilance
US FAERS
8FatigueFAERS: 341
Canada Vigilance: 8
Canada Vigilance
US FAERS
9Medication residueFAERS: 327US FAERS
10MalaiseFAERS: 262
Canada Vigilance: 6
Canada Vigilance
US FAERS
11CryingFAERS: 175
Canada Vigilance: 4
Canada Vigilance
US FAERS
12SomnolenceFAERS: 166
Canada Vigilance: 1
Canada Vigilance
US FAERS
13VomitingFAERS: 160
Canada Vigilance: 5
Canada Vigilance
US FAERS
14TremorFAERS: 158
Canada Vigilance: 7
Canada Vigilance
US FAERS
15AgitationFAERS: 136
Canada Vigilance: 12
Canada Vigilance
US FAERS
16NervousnessFAERS: 110
Canada Vigilance: 3
Canada Vigilance
US FAERS
17ConstipationFAERS: 109
Canada Vigilance: 1
Canada Vigilance
US FAERS
18PalpitationsFAERS: 107
Canada Vigilance: 2
Canada Vigilance
US FAERS
19AstheniaFAERS: 104US FAERS
20Depressed moodFAERS: 97
Canada Vigilance: 1
Canada Vigilance
US FAERS
21AngerFAERS: 95
Canada Vigilance: 2
Canada Vigilance
US FAERS
22PainFAERS: 90
Canada Vigilance: 3
Canada Vigilance
US FAERS
23AlopeciaFAERS: 84
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Emotional disorderFAERS: 81US FAERS
25TinnitusFAERS: 80
Canada Vigilance: 2
Canada Vigilance
US FAERS
26RestlessnessFAERS: 76US FAERS
27Abdominal discomfortFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Unevaluable eventFAERS: 72US FAERS
29Completed SuicideFAERS: 65
Canada Vigilance: 4
Canada Vigilance
US FAERS
30Weight decreasedFAERS: 65
Canada Vigilance: 4
Canada Vigilance
US FAERS
31Wrong technique in drug usage processFAERS: 64US FAERS
32ApathyFAERS: 63US FAERS
33MydriasisFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
34Feeling jitteryFAERS: 61US FAERS
35VertigoFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
36PruritusFAERS: 59US FAERS
37UrticariaFAERS: 53
Canada Vigilance: 2
Canada Vigilance
US FAERS
38MyalgiaFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Drug screen false positiveFAERS: 50US FAERS
40Drug screen positiveFAERS: 49US FAERS
41Intentional drug misuseFAERS: 49US FAERS
42Chest PainFAERS: 48
Canada Vigilance: 4
Canada Vigilance
US FAERS
43Activities of daily living impairedFAERS: 47US FAERS
44Blood cholesterol increasedFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Memory impairmentFAERS: 46
Canada Vigilance: 4
Canada Vigilance
US FAERS
46Visual ImpairmentFAERS: 45US FAERS
47Suicide attemptFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
48TachycardiaFAERS: 42US FAERS
49Sexual DysfunctionFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Psychiatric symptomFAERS: 38US FAERS
51AmnesiaFAERS: 36US FAERS
52TensionFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Drug DependenceFAERS: 35
Canada Vigilance: 4
Canada Vigilance
US FAERS
54ArthralgiaFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
55LethargyFAERS: 34US FAERS
56Feelings of worthlessnessFAERS: 33US FAERS
57HypersensitivityFAERS: 33US FAERS
58Negative thoughtsFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
59Nonspecific reactionFAERS: 30US FAERS
60Mood swingsFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
61StressFAERS: 29US FAERS
62ChillsFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
63DisorientationFAERS: 28US FAERS
64Impaired work abilityFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
65Abdominal PainFAERS: 27US FAERS
66HypersomniaFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
67DysgeusiaFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Night sweatsFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
69Therapeutic response unexpectedFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
70DyspepsiaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Middle insomniaFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
72Drug dose omissionFAERS: 24US FAERS
73Impaired driving abilityFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
74Myocardial InfarctionFAERS: 24US FAERS
75Back PainFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Product quality issueFAERS: 22US FAERS
77Restless Legs SyndromeFAERS: 22US FAERS
78SyncopeFAERS: 22
Canada Vigilance: 5
Canada Vigilance
US FAERS
79InfluenzaFAERS: 21US FAERS
80NasopharyngitisFAERS: 21US FAERS
81Bipolar DisorderFAERS: 20US FAERS
82Drug ineffective for unapproved indicationFAERS: 20US FAERS
83ParanoiaFAERS: 20
Canada Vigilance: 5
Canada Vigilance
US FAERS
84Serotonin SyndromeFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
85AnorgasmiaFAERS: 18US FAERS
86Blood triglycerides increasedFAERS: 18US FAERS
87BruxismFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
88ErythemaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
89FlatulenceFAERS: 18US FAERS
90Medication residue presentFAERS: 18US FAERS
91Urinary RetentionFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Blood glucose increasedFAERS: 17US FAERS
93DysuriaFAERS: 17US FAERS
94Erectile dysfunctionFAERS: 17US FAERS
95HostilityFAERS: 17US FAERS
96Mental impairmentFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
97Musculoskeletal stiffnessFAERS: 17US FAERS
98Chest discomfortFAERS: 16US FAERS
99DiscomfortFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Joint swellingFAERS: 16US FAERS
101Muscle tightnessFAERS: 16US FAERS
102Poor quality sleepFAERS: 16US FAERS
103Cerebrovascular accidentFAERS: 15US FAERS
104Drug effect incompleteFAERS: 15US FAERS
105EpistaxisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
106Lip swellingFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Personality ChangeFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
108HypotensionFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
109Incorrect dose administeredFAERS: 14US FAERS
110Burning sensationFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
111Feeling ColdFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
112GlaucomaFAERS: 13US FAERS
113Head discomfortFAERS: 13US FAERS
114DysarthriaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
115FibromyalgiaFAERS: 11US FAERS
116FrustrationFAERS: 11US FAERS
117No adverse eventFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
118SwellingFAERS: 11US FAERS
119Tardive DyskinesiaFAERS: 11US FAERS
120Drug exposure during pregnancyFAERS: 10US FAERS
121Euphoric moodFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Gastric BypassFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
123MenorrhagiaFAERS: 10US FAERS
124Neck PainFAERS: 10US FAERS
125ObesityFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
126OverdoseFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
127SinusitisFAERS: 10US FAERS
128YawningFAERS: 10US FAERS
129AcneFAERS: 9US FAERS
130AsphyxiaFAERS: 9US FAERS
131Cold sweatFAERS: 9US FAERS
132DiplopiaFAERS: 9US FAERS
133DissociationFAERS: 9US FAERS
134Drug administration errorFAERS: 9US FAERS
135Eye painFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Intentional product misuseFAERS: 9
Canada Vigilance: 6
Canada Vigilance
US FAERS
137Oropharyngeal painFAERS: 9US FAERS
138PhotophobiaFAERS: 9US FAERS
139PneumoniaFAERS: 9US FAERS
140Rash erythematousFAERS: 9US FAERS
141TachyphreniaFAERS: 9US FAERS
142Alanine Aminotransferase IncreasedFAERS: 8US FAERS
143AngioedemaFAERS: 8US FAERS
144AphasiaFAERS: 8US FAERS
145ArthropathyFAERS: 8US FAERS
146BlindnessFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Blood glucose decreasedFAERS: 8US FAERS
148DehydrationFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Emotional distressFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
150FormicationFAERS: 8US FAERS
151HungerFAERS: 8US FAERS
152Inappropriate schedule of drug administrationFAERS: 8US FAERS
153MalabsorptionFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
154Mental status changesFAERS: 8US FAERS
155Musculoskeletal PainFAERS: 8US FAERS
156PresyncopeFAERS: 8US FAERS
157SluggishnessFAERS: 8US FAERS
158StomatitisFAERS: 8US FAERS
159jaundiceFAERS: 8US FAERS
160AbasiaFAERS: 7US FAERS
161Accidental overdoseFAERS: 7US FAERS
162BedriddenFAERS: 7US FAERS
163Expired drug administeredFAERS: 7US FAERS
164Flat affectFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
165FlushingFAERS: 7US FAERS
166HyperacusisFAERS: 7US FAERS
167InflammationFAERS: 7US FAERS
168Initial insomniaFAERS: 7US FAERS
169Joint injuryFAERS: 7US FAERS
170Multiple SclerosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Panic DisorderFAERS: 7US FAERS
172Product formulation issueFAERS: 7US FAERS
173ThrombosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Urinary hesitationFAERS: 7US FAERS
175Violence-related symptomFAERS: 7US FAERS
176Accidental drug intake by childFAERS: 6US FAERS
177AkathisiaFAERS: 6US FAERS
178Diabetes MellitusFAERS: 6US FAERS
179NeutropeniaFAERS: 6US FAERS
180Obsessive thoughtsFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Obsessive-Compulsive DisorderFAERS: 6US FAERS
182PancreatitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
183Sjogren's SyndromeFAERS: 6US FAERS
184SomnambulismFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
185Throat irritationFAERS: 6US FAERS
186nervous system disorderFAERS: 6US FAERS
187Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
188AsthenopiaFAERS: 5US FAERS
189Atrial FibrillationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Blood testosterone decreasedFAERS: 5US FAERS
191BronchitisFAERS: 5US FAERS
192CataractFAERS: 5US FAERS
193CheilitisFAERS: 5US FAERS
194DysphoniaFAERS: 5US FAERS
195DystoniaFAERS: 5US FAERS
196Feeling of body temperature changeFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
197HypothyroidismFAERS: 5US FAERS
198ImpatienceFAERS: 5US FAERS
199Maternal exposure during pregnancyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
200MyoclonusFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Product use in unapproved indicationFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
202Sinus headacheFAERS: 5US FAERS
203TrismusFAERS: 5US FAERS
204Alcohol interactionFAERS: 4US FAERS
205Altered state of consciousnessFAERS: 4US FAERS
206Angle Closure GlaucomaFAERS: 4US FAERS
207AnhedoniaFAERS: 4US FAERS
208AnorexiaFAERS: 4US FAERS
209AphagiaFAERS: 4US FAERS
210ArthritisFAERS: 4US FAERS
211Back disorderFAERS: 4US FAERS
212Blood pressure fluctuationFAERS: 4US FAERS
213Blood prolactin increasedFAERS: 4US FAERS
214Blood urine presentFAERS: 4US FAERS
215Bone painFAERS: 4US FAERS
216Bowel movement irregularityFAERS: 4US FAERS
217BradycardiaFAERS: 4US FAERS
218Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
219DeliriumFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
220DependenceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
221Depression suicidalFAERS: 4US FAERS
222Drug dispensing errorFAERS: 4US FAERS
223Drug prescribing errorFAERS: 4US FAERS
224DysphemiaFAERS: 4US FAERS
225EpilepsyFAERS: 4US FAERS
226Gastrointestinal PainFAERS: 4US FAERS
227GoutFAERS: 4US FAERS
228HepatitisFAERS: 4US FAERS
229Hypoaesthesia facialFAERS: 4US FAERS
230HypomaniaFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
231Impaired gastric emptyingFAERS: 4US FAERS
232IncontinenceFAERS: 4US FAERS
233Low density lipoprotein increasedFAERS: 4US FAERS
234Male sexual dysfunctionFAERS: 4US FAERS
235Medication ErrorFAERS: 4US FAERS
236Motion SicknessFAERS: 4US FAERS
237NephrolithiasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Poor quality drug administeredFAERS: 4US FAERS
239Product container issueFAERS: 4US FAERS
240Product solubility abnormalFAERS: 4US FAERS
241Quality of life decreasedFAERS: 4US FAERS
242RhabdomyolysisFAERS: 4US FAERS
243ScreamingFAERS: 4US FAERS
244Skin lacerationFAERS: 4US FAERS
245ThrombocytopeniaFAERS: 4US FAERS
246Amphetamines positiveFAERS: 3US FAERS
247Ankle FractureFAERS: 3US FAERS
248Autoimmune thyroiditisFAERS: 3US FAERS
249Bipolar I disorderFAERS: 3US FAERS
250Blood sodium decreasedFAERS: 3US FAERS
251Cardiac ArrestFAERS: 3US FAERS
252Cardiac FlutterFAERS: 3US FAERS
253Choking sensationFAERS: 3US FAERS
254ChokingFAERS: 3US FAERS
255Drug abuserFAERS: 3US FAERS
256Drug abuseFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
257Economic problemFAERS: 3US FAERS
258Elevated moodFAERS: 3US FAERS
259Endodontic procedureFAERS: 3US FAERS
260Facial PainFAERS: 3US FAERS
261False positive investigation resultFAERS: 3US FAERS
262Food cravingFAERS: 3US FAERS
263GastroenteritisFAERS: 3US FAERS
264Gastrointestinal sounds abnormalFAERS: 3US FAERS
265General physical condition abnormalFAERS: 3US FAERS
266Inappropriate affectFAERS: 3US FAERS
267Irritable Bowel SyndromeFAERS: 3US FAERS
268Libido disorderFAERS: 3US FAERS
269Limb discomfortFAERS: 3US FAERS
270Loss of personal independence in daily activitiesFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
271MenopauseFAERS: 3US FAERS
272Musculoskeletal discomfortFAERS: 3US FAERS
273Oral painFAERS: 3US FAERS
274Pain of skinFAERS: 3US FAERS
275PallorFAERS: 3US FAERS
276PoisoningFAERS: 3US FAERS
277PolyuriaFAERS: 3US FAERS
278Post-Traumatic Stress DisorderFAERS: 3US FAERS
279PsoriasisFAERS: 3US FAERS
280Pulmonary EmbolismFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
281Reaction to drug excipientsFAERS: 3US FAERS
282Rebound effectFAERS: 3US FAERS
283Renal massFAERS: 3US FAERS
284RetchingFAERS: 3US FAERS
285Rheumatoid ArthritisFAERS: 3US FAERS
286Skin necrosisFAERS: 3US FAERS
287Skin reactionFAERS: 3US FAERS
288StaringFAERS: 3US FAERS
289Supraventricular tachycardiaFAERS: 3US FAERS
290Tension HeadacheFAERS: 3US FAERS
291Urinary IncontinenceFAERS: 3US FAERS
292Urine flow decreasedFAERS: 3US FAERS
293Vaginal DischargeFAERS: 3US FAERS
294Adnexa uteri painFAERS: 2US FAERS
295Alcohol poisoningFAERS: 2US FAERS
296Anorectal discomfortFAERS: 2US FAERS
297AnosmiaFAERS: 2US FAERS
298Apparent deathFAERS: 2US FAERS
299AsthmaFAERS: 2US FAERS
300AtaxiaFAERS: 2US FAERS
301Atrial FlutterFAERS: 2US FAERS
302BlepharospasmFAERS: 2US FAERS
303Blood alkaline phosphatase increasedFAERS: 2US FAERS
304Blood glucose fluctuationFAERS: 2US FAERS
305BradyphreniaFAERS: 2US FAERS
306Breast tendernessFAERS: 2US FAERS
307CholelithiasisFAERS: 2US FAERS
308ChromaturiaFAERS: 2US FAERS
309ClumsinessFAERS: 2US FAERS
310DeafnessFAERS: 2US FAERS
311Disease recurrenceFAERS: 2US FAERS
312Dreamy stateFAERS: 2US FAERS
313Drug ToleranceFAERS: 2US FAERS
314Drug screen negativeFAERS: 2US FAERS
315Dry skinFAERS: 2US FAERS
316Ear discomfortFAERS: 2US FAERS
317EcchymosisFAERS: 2US FAERS
318Electrocardiogram abnormalFAERS: 2US FAERS
319Electroencephalogram abnormalFAERS: 2US FAERS
320EructationFAERS: 2US FAERS
321Erythema MultiformeFAERS: 2US FAERS
322ExophthalmosFAERS: 2US FAERS
323Eye irritationFAERS: 2US FAERS
324Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
325General physical health deteriorationFAERS: 2US FAERS
326Hepatitis CFAERS: 2US FAERS
327HyperphagiaFAERS: 2US FAERS
328Hypertensive crisisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
329Intentional self-injuryFAERS: 2US FAERS
330Joint Range of Motion DecreasedFAERS: 2US FAERS
331Joint stiffnessFAERS: 2US FAERS
332LabyrinthitisFAERS: 2US FAERS
333LaryngitisFAERS: 2US FAERS
334Limb injuryFAERS: 2US FAERS
335Muscle RigidityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
336MyopiaFAERS: 2US FAERS
337Nerve injuryFAERS: 2US FAERS
338Neuroleptic Malignant SyndromeFAERS: 2US FAERS
339NocturiaFAERS: 2US FAERS
340Oculogyric crisisFAERS: 2US FAERS
341Oropharyngeal discomfortFAERS: 2US FAERS
342OverweightFAERS: 2US FAERS
343Partner stressFAERS: 2US FAERS
344Platelet function test abnormalFAERS: 2US FAERS
345Pre-existing condition improvedFAERS: 2US FAERS
346Product label issueFAERS: 2US FAERS
347Product residue presentFAERS: 2
Canada Vigilance: 8
Canada Vigilance
US FAERS
348Product size issueFAERS: 2US FAERS
349Prostatic painFAERS: 2US FAERS
350Radiation necrosisFAERS: 2US FAERS
351ShockFAERS: 2US FAERS
352Sinus TachycardiaFAERS: 2US FAERS
353Skin irritationFAERS: 2US FAERS
354Spinal column injuryFAERS: 2US FAERS
355Stevens-Johnson SyndromeFAERS: 2US FAERS
356Suppressed lactationFAERS: 2US FAERS
357Tablet physical issueFAERS: 2US FAERS
358TachyphylaxisFAERS: 2US FAERS
359Temperature intoleranceFAERS: 2US FAERS
360ThirstFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
361Tooth ExtractionFAERS: 2US FAERS
362ToothacheFAERS: 2US FAERS
363Unresponsive to stimuliFAERS: 2US FAERS
364Uterine spasmFAERS: 2US FAERS
365Vitamin D DeficiencyFAERS: 2US FAERS
366Vitreous floatersFAERS: 2US FAERS
367Vulvovaginal discomfortFAERS: 2US FAERS
368Abnormal sleep-related eventFAERS: 1US FAERS
369AbscessFAERS: 1US FAERS
370AbuliaFAERS: 1US FAERS
371Accidental deathFAERS: 1US FAERS
372Acute myocardial infarctionFAERS: 1US FAERS
373Adverse eventFAERS: 1US FAERS
374AgeusiaFAERS: 1US FAERS
375AgoraphobiaFAERS: 1US FAERS
376Alcohol problemFAERS: 1US FAERS
377Alcohol test false positiveFAERS: 1US FAERS
378Allergic reaction to excipientFAERS: 1US FAERS
379Altered visual depth perceptionFAERS: 1US FAERS
380AmblyopiaFAERS: 1US FAERS
381Anaphylactic shockFAERS: 1US FAERS
382Angina PectorisFAERS: 1US FAERS
383Aortic AneurysmFAERS: 1US FAERS
384Aphthous StomatitisFAERS: 1US FAERS
385Atrioventricular BlockFAERS: 1US FAERS
386Autoimmune hepatitisFAERS: 1US FAERS
387AutoscopyFAERS: 1US FAERS
388AversionFAERS: 1US FAERS
389BelligerenceFAERS: 1US FAERS
390Benign Prostatic HyperplasiaFAERS: 1US FAERS
391Biotin deficiencyFAERS: 1US FAERS
392BlepharopachynsisFAERS: 1US FAERS
393Blood blisterFAERS: 1US FAERS
394Blood cholesterol abnormalFAERS: 1US FAERS
395Blood cortisol increasedFAERS: 1US FAERS
396Blood immunoglobulin G increasedFAERS: 1US FAERS
397Blood iron decreasedFAERS: 1US FAERS
398Blood iron increasedFAERS: 1US FAERS
399Blood potassium decreasedFAERS: 1US FAERS
400Blood potassium increasedFAERS: 1US FAERS
401Blood sodium abnormalFAERS: 1US FAERS
402Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
403Breast cancer recurrentFAERS: 1US FAERS
404Breast engorgementFAERS: 1US FAERS
405Bronchial HyperreactivityFAERS: 1US FAERS
406BursitisFAERS: 1US FAERS
407Cataract operation complicationFAERS: 1US FAERS
408CellulitisFAERS: 1US FAERS
409ClaustrophobiaFAERS: 1US FAERS
410Clostridium difficile infectionFAERS: 1US FAERS
411Congenital cystic kidney diseaseFAERS: 1US FAERS
412Congenital renal disorderFAERS: 1US FAERS
413ConjunctivitisFAERS: 1US FAERS
414Contact lens complicationFAERS: 1US FAERS
415Conversion disorderFAERS: 1US FAERS
416CystitisFAERS: 1US FAERS
417CystFAERS: 1US FAERS
418Dehydroepiandrosterone decreasedFAERS: 1US FAERS
419DementiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
420Dermatitis HerpetiformisFAERS: 1US FAERS
421DisabilityFAERS: 1US FAERS
422Disturbance in sexual arousalFAERS: 1US FAERS
423DroolingFAERS: 1US FAERS
424Drug administered to patient of inappropriate ageFAERS: 1US FAERS
425Drug effect delayedFAERS: 1US FAERS
426Drug effect variableFAERS: 1US FAERS
427Drug exposure via breast milkFAERS: 1US FAERS
428Drug half-life reducedFAERS: 1US FAERS
429Drug withdrawal convulsionsFAERS: 1US FAERS
430DysenteryFAERS: 1US FAERS
431DysgraphiaFAERS: 1US FAERS
432DyspareuniaFAERS: 1US FAERS
433EczemaFAERS: 1US FAERS
434Electrocardiogram ST segment abnormalFAERS: 1US FAERS
435Electrocardiogram changeFAERS: 1US FAERS
436Electrolyte imbalanceFAERS: 1US FAERS
437Emotional povertyFAERS: 1US FAERS
438Epinephrine increasedFAERS: 1US FAERS
439Erection increasedFAERS: 1US FAERS
440Excessive eye blinkingFAERS: 1US FAERS
441Excessive sexual fantasiesFAERS: 1US FAERS
442Exfoliative rashFAERS: 1US FAERS
443Extra dose administeredFAERS: 1US FAERS
444Eye InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
445Eyelid Function DisorderFAERS: 1US FAERS
446Factor VIII DeficiencyFAERS: 1US FAERS
447False negative investigation resultFAERS: 1US FAERS
448Female sexual dysfunctionFAERS: 1US FAERS
449Flank PainFAERS: 1US FAERS
450Food AllergyFAERS: 1US FAERS
451FractureFAERS: 1US FAERS
452Frustration tolerance decreasedFAERS: 1US FAERS
453GastritisFAERS: 1US FAERS
454Gastrointestinal bacterial infectionFAERS: 1US FAERS
455Gastrointestinal stoma complicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
456Genital HerpesFAERS: 1US FAERS
457Genital discomfortFAERS: 1US FAERS
458Genital painFAERS: 1US FAERS
459GingivitisFAERS: 1US FAERS
460Grief reactionFAERS: 1US FAERS
461Hand-eye coordination impairedFAERS: 1US FAERS
462Head titubationFAERS: 1US FAERS
463HepatotoxicityFAERS: 1US FAERS
464HerniaFAERS: 1US FAERS
465HomicideFAERS: 1US FAERS
466Hormone level abnormalFAERS: 1US FAERS
467HydrocephalusFAERS: 1US FAERS
468HyperthyroidismFAERS: 1US FAERS
469HypokinesiaFAERS: 1US FAERS
470HypoxiaFAERS: 1US FAERS
471Immune thrombocytopenic purpuraFAERS: 1US FAERS
472IncoherentFAERS: 1US FAERS
473Incorrect drug dosage form administeredFAERS: 1US FAERS
474Increased tendency to bruiseFAERS: 1US FAERS
475InfarctionFAERS: 1US FAERS
476Infectious MononucleosisFAERS: 1US FAERS
477Injury associated with deviceFAERS: 1US FAERS
478Intentional product use issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
479Intercepted drug dispensing errorFAERS: 1US FAERS
480Intestinal PerforationFAERS: 1US FAERS
481Intracranial AneurysmFAERS: 1US FAERS
482Intraocular pressure test abnormalFAERS: 1US FAERS
483Joint destructionFAERS: 1US FAERS
484KeratitisFAERS: 1US FAERS
485LacerationFAERS: 1US FAERS
486Lack of spontaneous speechFAERS: 1US FAERS
487LazinessFAERS: 1US FAERS
488LeukopeniaFAERS: 1US FAERS
489Limb crushing injuryFAERS: 1US FAERS
490Lip exfoliationFAERS: 1US FAERS
491LymphadenopathyFAERS: 1US FAERS
492LymphomaFAERS: 1US FAERS
493Male Orgasmic DisorderFAERS: 1US FAERS
494MastitisFAERS: 1US FAERS
495MastoiditisFAERS: 1US FAERS
496Maternal exposure timing unspecifiedFAERS: 1US FAERS
497Mechanical urticariaFAERS: 1US FAERS
498MetrorrhagiaFAERS: 1US FAERS
499Micturition frequency decreasedFAERS: 1US FAERS
500Migraine with AuraFAERS: 1US FAERS
501Mixed liver injuryFAERS: 1US FAERS
502Morbid thoughtsFAERS: 1US FAERS
503Muscle FatigueFAERS: 1US FAERS
504NarcolepsyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
505NeuralgiaFAERS: 1US FAERS
506Neurological examination abnormalFAERS: 1US FAERS
507Norepinephrine decreasedFAERS: 1US FAERS
508Occupational exposure to productFAERS: 1US FAERS
509OliguriaFAERS: 1US FAERS
510OnychoclasisFAERS: 1US FAERS
511Opiates positiveFAERS: 1US FAERS
512Oral mucosal erythemaFAERS: 1US FAERS
513Pancreatic carcinomaFAERS: 1US FAERS
514Paranoid Personality DisorderFAERS: 1US FAERS
515Pelvic PainFAERS: 1US FAERS
516Pelvic discomfortFAERS: 1US FAERS
517Penile size reducedFAERS: 1US FAERS
518Peripheral arterial occlusive diseaseFAERS: 1US FAERS
519Phobia of drivingFAERS: 1US FAERS
520PiloerectionFAERS: 1US FAERS
521Plastic surgery to the faceFAERS: 1US FAERS
522Platelet count abnormalFAERS: 1US FAERS
523Poor peripheral circulationFAERS: 1US FAERS
524Poor personal hygieneFAERS: 1US FAERS
525Poverty of speechFAERS: 1US FAERS
526PregnancyFAERS: 1US FAERS
527Pressure of speechFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
528Product measured potency issueFAERS: 1US FAERS
529Product packaging quantity issueFAERS: 1US FAERS
530Product physical issueFAERS: 1US FAERS
531Product shape issueFAERS: 1US FAERS
532Product substitution issueFAERS: 1US FAERS
533Product use issueFAERS: 1US FAERS
534Productive CoughFAERS: 1US FAERS
535Protein urine presentFAERS: 1US FAERS
536ProteinuriaFAERS: 1US FAERS
537Psychiatric decompensationFAERS: 1US FAERS
538Pulmonary FibrosisFAERS: 1US FAERS
539Reaction to excipientFAERS: 1US FAERS
540RegurgitationFAERS: 1US FAERS
541Renal cystFAERS: 1US FAERS
542Renal painFAERS: 1US FAERS
543Renal vessel congenital anomalyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
544Respiratory FailureFAERS: 1US FAERS
545Respiratory arrestFAERS: 1US FAERS
546Rocky Mountain Spotted FeverFAERS: 1US FAERS
547RosaceaFAERS: 1US FAERS
548Rotator cuff syndromeFAERS: 1US FAERS
549Saliva alteredFAERS: 1US FAERS
550SchizophreniaFAERS: 1US FAERS
551Sinus bradycardiaFAERS: 1US FAERS
552Sinus operationFAERS: 1US FAERS
553Skin UlcerFAERS: 1US FAERS
554Skin lesionFAERS: 1US FAERS
555Sleep ParalysisFAERS: 1US FAERS
556Sleep TalkingFAERS: 1US FAERS
557Slow speechFAERS: 1US FAERS
558Sperm concentration abnormalFAERS: 1US FAERS
559Sperm count decreasedFAERS: 1US FAERS
560Spermatozoa progressive motility decreasedFAERS: 1US FAERS
561Spinal rod insertionFAERS: 1US FAERS
562StuporFAERS: 1US FAERS
563Sudden onset of sleepFAERS: 1US FAERS
564Superficial vein prominenceFAERS: 1US FAERS
565Suspected counterfeit productFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
566Therapeutic product effect decreasedFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
567Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
568Therapeutic reaction time decreasedFAERS: 1US FAERS
569Therapeutic response changedFAERS: 1US FAERS
570Therapy non-responderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
571Therapy regimen changedFAERS: 1US FAERS
572Thermal burnFAERS: 1US FAERS
573Thoracic vertebral fractureFAERS: 1US FAERS
574Thyroid NeoplasmFAERS: 1US FAERS
575Tobacco userFAERS: 1US FAERS
576Tobacco withdrawal symptomsFAERS: 1US FAERS
577Toxicity to various agentsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
578TrichorrhexisFAERS: 1US FAERS
579UlcerFAERS: 1US FAERS
580Upper-airway cough syndromeFAERS: 1US FAERS
581Urethral dischargeFAERS: 1US FAERS
582Urinary tract infectionFAERS: 1US FAERS
583Urine osmolarity decreasedFAERS: 1US FAERS
584UveitisFAERS: 1US FAERS
585VIIth nerve paralysisFAERS: 1US FAERS
586Vaginal lesionFAERS: 1US FAERS
587Vascular painFAERS: 1US FAERS
588Ventricular FibrillationFAERS: 1US FAERS
589Visual brightnessFAERS: 1US FAERS
590Vulvovaginal drynessFAERS: 1US FAERS
591heart rateFAERS: 1US FAERS
592Antidepressant drug clearance decreasedCanada Vigilance: 1Canada Vigilance
593Borderline Personality DisorderCanada Vigilance: 1Canada Vigilance
594Decreased eye contactCanada Vigilance: 2Canada Vigilance
595DermatomyositisCanada Vigilance: 1Canada Vigilance
596Executive dysfunctionCanada Vigilance: 2Canada Vigilance
597Foreign body in respiratory tractCanada Vigilance: 1Canada Vigilance
598Hallucinations, mixedCanada Vigilance: 2Canada Vigilance
599Increased viscosity of bronchial secretionCanada Vigilance: 1Canada Vigilance
600Prescribed overdoseCanada Vigilance: 3Canada Vigilance
601Product dose omissionCanada Vigilance: 2Canada Vigilance
602Product prescribing errorCanada Vigilance: 1Canada Vigilance
603Respiratory tract irritationCanada Vigilance: 1Canada Vigilance
604Therapy changeCanada Vigilance: 2Canada Vigilance
605Wrong technique in product usage processCanada Vigilance: 1Canada Vigilance
606treatment failureCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.